We measured several plasma biomarkers of endothelial cell activation (soluble E-selectin, soluble ICAM-1 and fractalkine) [37] and barrier function (angiopoietin-1 and angiopoietin-2) [37], neither of which was modified in patients with diabetes mellitus. The gene discussed is ICAM1; the disease is diabetes mellitus.